Although prostate cancer is a known immunogenic disease, it can escape the immune system by downregulating human leukocyte antigen class I and thereby render antigen presentation ineffective by secreting immunosuppressive cytokines such as TGF-β or by increasing regulatory T cells (Tregs)40,41. The gene discussed is TGFB1; the disease is prostate carcinoma.